Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-26-025764·20/20 Biolabs, Inc.
Schedule 13D ownership disclosure
20/20 BIOLABS INC
Common Stock, par value $0.01 · CUSIP: 90138K101
Event date: 2026-03-03
- Filing-level shares
- 1,833,750.00
- Percent of class
- 16.8%
- Jonathan M CohenReported CIK 0002111543
Shares: 1,833,750.00 · Class: 16.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-26-025764
- Form type
- SCHEDULE 13D
- Filer
- 20/20 Biolabs, Inc.
- CIK
- CIK 1139685
- Filed
- Mar 10, 2026
- Reporting period
- Mar 03, 2026
- Description
- Schedule 13D beneficial ownership